Security key
00688A205
Adial Pharmaceuticals, Inc. - Common Stock (ADIL)
CUSIP: 00688A205
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 5,493,768
- Total 13F shares
- 234,705
- Share change
- +65
- Total reported value
- $70,153
- Price per share
- $0.30
- Number of holders
- 16
- Value change
- -$9,760
- Number of buys
- 7
- Number of sells
- 3
Report period
Q2 2025
Institutions
16
Top holders
10
ADIL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
ADIAL PHARMACEUTICALS, INC. SEC filings
ADIAL PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00688A205
Recent filing periods:
Ownership snapshot
Top shareholders of ADIL - Adial Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
INTRACOASTAL CAPITAL, LLC
13D/G signal
INTRACOASTAL CAPITAL, LLC
Evidence rows
18
Latest as of
17 Jun 2025
13D/G
13F
3/4/5
Lead comparable stake: 2.8%
13D/G row: INTRACOASTAL CAPITAL, LLC
Showing first 8 of 18 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
2.8%
|
$325,786
446,282 shares
|
$0 | 17 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.3%
|
$43,664
68,850 shares
|
— | 31 Mar 2025 |
| Manchester Capital Management LLC |
13F
Company
|
0.88%
|
$30,504
48,097 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
0.87%
|
$30,270
47,745 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
0.51%
|
$17,612
27,770 shares
|
— | 31 Mar 2025 |
| Virtu Financial LLC |
13F
Company
|
0.48%
|
$17,000
26,414 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.24%
|
$8,343
13,159 shares
|
— | 31 Mar 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.03%
|
$905
1,427 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
234,705
Rows loaded
16
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
12
Q2 2025 holders
16
Holder diff
4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend